The Valley Desk

NCT04493853 · Interventional trial

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Overall registry status Active not recruiting

Phase 3

Conditions Hormone-Sensitive Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov